Clinical Trial

Banca di Materiale Biologico Per lo Studio di Patologie Che Interessano l'Apparato Muscolo-scheletrico

Study acronym: BioBanca
Recruiting
View on ClinicalTrials.gov →
Summary
Musculoskeletal disorders are an heterogeneous group of diseases that represent one of the major causes of disability. Considering the importance of studying these pathologies, it is necessary to develop research lines based on the availability of human biological material from highly clinically relevant patients. The purpose of this project is therefore the establishment of a bank of biological material (biobank) to investigate important aspects related to the pathologies of the musculoskeletal system through subsequent bio-molecular characterization studies.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2017-06-30; most recent amendment 2025-02-13.
Status change: Enrolling by Invitation → Recruiting 2024-02-21
Trial Details
NCT Number NCT03208062
Lead Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions Tissue Banking
Enrollment 1,500 participants
Start Date 2017-05-31
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-17